With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and safe treatments. VMX-C001 Immediately restores blood clotting in the presence of direct factor Xa anticoagulants.